Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults

NCT04886050 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Hyperuricemia

Interventions

DRUG: LC350189 Tablet
DRUG: LC350189 Capsule

Sponsor

LG Chem